 | • レポートコード：MRC308GR11482 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の神経系治療薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の神経系治療薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 神経系治療薬の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
神経系治療薬市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・麻酔薬、鎮痛薬、精神興奮薬、抗てんかん薬、抗パーキンソン病薬、その他
用途別セグメント
・病院薬局、小売薬局、オンライン薬局
主要な市場プレーヤー
・Pfizer、Teva、Novartis、AstraZeneca、Takeda、Johnson & Johnson、EliLilly、Otsuka、Merck、Yangtze River Pharmaceutical、Humanwell Healthcare、CSPC-NBP Pharmaceutical、Nhwa Pharmaceutical、Qilu Pharma
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、神経系治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な神経系治療薬メーカーの企業概要、2019年～2022年までの神経系治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な神経系治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別神経系治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの神経系治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での神経系治療薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および神経系治療薬の産業チェーンを掲載しています。
・第14、15章では、神経系治療薬の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 神経系治療薬の概要
– 種類別分析（2018年vs2022年vs2029年）：麻酔薬、鎮痛薬、精神興奮薬、抗てんかん薬、抗パーキンソン病薬、その他
– 用途別分析（2018年vs2022年vs2029年）：病院薬局、小売薬局、オンライン薬局
– 世界の神経系治療薬市場規模・予測
– 世界の神経系治療薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Pfizer、Teva、Novartis、AstraZeneca、Takeda、Johnson & Johnson、EliLilly、Otsuka、Merck、Yangtze River Pharmaceutical、Humanwell Healthcare、CSPC-NBP Pharmaceutical、Nhwa Pharmaceutical、Qilu Pharma
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：麻酔薬、鎮痛薬、精神興奮薬、抗てんかん薬、抗パーキンソン病薬、その他
・用途別分析2018年-2029年：病院薬局、小売薬局、オンライン薬局
・神経系治療薬の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・神経系治療薬のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・神経系治療薬のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・神経系治療薬の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・神経系治療薬の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Nervous System Medications
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Nervous System Medications Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Anesthetic
1.3.3 Painkiller
1.3.4 Psychostimulants
1.3.5 Antiepileptic Drugs
1.3.6 Anti-Parkinson Drugs
1.3.7 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Nervous System Medications Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacy
1.4.3 Retail Pharmacy
1.4.4 Online Pharmacy
1.5 Global Nervous System Medications Market Size & Forecast
1.5.1 Global Nervous System Medications Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Nervous System Medications Sales Quantity (2018-2029)
1.5.3 Global Nervous System Medications Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Nervous System Medications Product and Services
2.1.4 Pfizer Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments/Updates
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Nervous System Medications Product and Services
2.2.4 Teva Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Teva Recent Developments/Updates
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Nervous System Medications Product and Services
2.3.4 Novartis Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novartis Recent Developments/Updates
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business
2.4.3 AstraZeneca Nervous System Medications Product and Services
2.4.4 AstraZeneca Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 AstraZeneca Recent Developments/Updates
2.5 Takeda
2.5.1 Takeda Details
2.5.2 Takeda Major Business
2.5.3 Takeda Nervous System Medications Product and Services
2.5.4 Takeda Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Takeda Recent Developments/Updates
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Nervous System Medications Product and Services
2.6.4 Johnson & Johnson Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Johnson & Johnson Recent Developments/Updates
2.7 EliLilly
2.7.1 EliLilly Details
2.7.2 EliLilly Major Business
2.7.3 EliLilly Nervous System Medications Product and Services
2.7.4 EliLilly Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 EliLilly Recent Developments/Updates
2.8 Otsuka
2.8.1 Otsuka Details
2.8.2 Otsuka Major Business
2.8.3 Otsuka Nervous System Medications Product and Services
2.8.4 Otsuka Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Otsuka Recent Developments/Updates
2.9 Merck
2.9.1 Merck Details
2.9.2 Merck Major Business
2.9.3 Merck Nervous System Medications Product and Services
2.9.4 Merck Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Merck Recent Developments/Updates
2.10 Yangtze River Pharmaceutical
2.10.1 Yangtze River Pharmaceutical Details
2.10.2 Yangtze River Pharmaceutical Major Business
2.10.3 Yangtze River Pharmaceutical Nervous System Medications Product and Services
2.10.4 Yangtze River Pharmaceutical Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Yangtze River Pharmaceutical Recent Developments/Updates
2.11 Humanwell Healthcare
2.11.1 Humanwell Healthcare Details
2.11.2 Humanwell Healthcare Major Business
2.11.3 Humanwell Healthcare Nervous System Medications Product and Services
2.11.4 Humanwell Healthcare Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Humanwell Healthcare Recent Developments/Updates
2.12 CSPC-NBP Pharmaceutical
2.12.1 CSPC-NBP Pharmaceutical Details
2.12.2 CSPC-NBP Pharmaceutical Major Business
2.12.3 CSPC-NBP Pharmaceutical Nervous System Medications Product and Services
2.12.4 CSPC-NBP Pharmaceutical Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 CSPC-NBP Pharmaceutical Recent Developments/Updates
2.13 Nhwa Pharmaceutical
2.13.1 Nhwa Pharmaceutical Details
2.13.2 Nhwa Pharmaceutical Major Business
2.13.3 Nhwa Pharmaceutical Nervous System Medications Product and Services
2.13.4 Nhwa Pharmaceutical Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Nhwa Pharmaceutical Recent Developments/Updates
2.14 Qilu Pharma
2.14.1 Qilu Pharma Details
2.14.2 Qilu Pharma Major Business
2.14.3 Qilu Pharma Nervous System Medications Product and Services
2.14.4 Qilu Pharma Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Qilu Pharma Recent Developments/Updates
3 Competitive Environment: Nervous System Medications by Manufacturer
3.1 Global Nervous System Medications Sales Quantity by Manufacturer (2018-2023)
3.2 Global Nervous System Medications Revenue by Manufacturer (2018-2023)
3.3 Global Nervous System Medications Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Nervous System Medications by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Nervous System Medications Manufacturer Market Share in 2022
3.4.2 Top 6 Nervous System Medications Manufacturer Market Share in 2022
3.5 Nervous System Medications Market: Overall Company Footprint Analysis
3.5.1 Nervous System Medications Market: Region Footprint
3.5.2 Nervous System Medications Market: Company Product Type Footprint
3.5.3 Nervous System Medications Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Nervous System Medications Market Size by Region
4.1.1 Global Nervous System Medications Sales Quantity by Region (2018-2029)
4.1.2 Global Nervous System Medications Consumption Value by Region (2018-2029)
4.1.3 Global Nervous System Medications Average Price by Region (2018-2029)
4.2 North America Nervous System Medications Consumption Value (2018-2029)
4.3 Europe Nervous System Medications Consumption Value (2018-2029)
4.4 Asia-Pacific Nervous System Medications Consumption Value (2018-2029)
4.5 South America Nervous System Medications Consumption Value (2018-2029)
4.6 Middle East and Africa Nervous System Medications Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Nervous System Medications Sales Quantity by Type (2018-2029)
5.2 Global Nervous System Medications Consumption Value by Type (2018-2029)
5.3 Global Nervous System Medications Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Nervous System Medications Sales Quantity by Application (2018-2029)
6.2 Global Nervous System Medications Consumption Value by Application (2018-2029)
6.3 Global Nervous System Medications Average Price by Application (2018-2029)
7 North America
7.1 North America Nervous System Medications Sales Quantity by Type (2018-2029)
7.2 North America Nervous System Medications Sales Quantity by Application (2018-2029)
7.3 North America Nervous System Medications Market Size by Country
7.3.1 North America Nervous System Medications Sales Quantity by Country (2018-2029)
7.3.2 North America Nervous System Medications Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Nervous System Medications Sales Quantity by Type (2018-2029)
8.2 Europe Nervous System Medications Sales Quantity by Application (2018-2029)
8.3 Europe Nervous System Medications Market Size by Country
8.3.1 Europe Nervous System Medications Sales Quantity by Country (2018-2029)
8.3.2 Europe Nervous System Medications Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Nervous System Medications Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Nervous System Medications Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Nervous System Medications Market Size by Region
9.3.1 Asia-Pacific Nervous System Medications Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Nervous System Medications Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Nervous System Medications Sales Quantity by Type (2018-2029)
10.2 South America Nervous System Medications Sales Quantity by Application (2018-2029)
10.3 South America Nervous System Medications Market Size by Country
10.3.1 South America Nervous System Medications Sales Quantity by Country (2018-2029)
10.3.2 South America Nervous System Medications Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Nervous System Medications Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Nervous System Medications Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Nervous System Medications Market Size by Country
11.3.1 Middle East & Africa Nervous System Medications Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Nervous System Medications Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Nervous System Medications Market Drivers
12.2 Nervous System Medications Market Restraints
12.3 Nervous System Medications Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Nervous System Medications and Key Manufacturers
13.2 Manufacturing Costs Percentage of Nervous System Medications
13.3 Nervous System Medications Production Process
13.4 Nervous System Medications Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Nervous System Medications Typical Distributors
14.3 Nervous System Medications Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Nervous System Medications Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Nervous System Medications Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Nervous System Medications Product and Services
Table 6. Pfizer Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer Recent Developments/Updates
Table 8. Teva Basic Information, Manufacturing Base and Competitors
Table 9. Teva Major Business
Table 10. Teva Nervous System Medications Product and Services
Table 11. Teva Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Teva Recent Developments/Updates
Table 13. Novartis Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Major Business
Table 15. Novartis Nervous System Medications Product and Services
Table 16. Novartis Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Novartis Recent Developments/Updates
Table 18. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 19. AstraZeneca Major Business
Table 20. AstraZeneca Nervous System Medications Product and Services
Table 21. AstraZeneca Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. AstraZeneca Recent Developments/Updates
Table 23. Takeda Basic Information, Manufacturing Base and Competitors
Table 24. Takeda Major Business
Table 25. Takeda Nervous System Medications Product and Services
Table 26. Takeda Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Takeda Recent Developments/Updates
Table 28. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 29. Johnson & Johnson Major Business
Table 30. Johnson & Johnson Nervous System Medications Product and Services
Table 31. Johnson & Johnson Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Johnson & Johnson Recent Developments/Updates
Table 33. EliLilly Basic Information, Manufacturing Base and Competitors
Table 34. EliLilly Major Business
Table 35. EliLilly Nervous System Medications Product and Services
Table 36. EliLilly Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. EliLilly Recent Developments/Updates
Table 38. Otsuka Basic Information, Manufacturing Base and Competitors
Table 39. Otsuka Major Business
Table 40. Otsuka Nervous System Medications Product and Services
Table 41. Otsuka Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Otsuka Recent Developments/Updates
Table 43. Merck Basic Information, Manufacturing Base and Competitors
Table 44. Merck Major Business
Table 45. Merck Nervous System Medications Product and Services
Table 46. Merck Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Merck Recent Developments/Updates
Table 48. Yangtze River Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 49. Yangtze River Pharmaceutical Major Business
Table 50. Yangtze River Pharmaceutical Nervous System Medications Product and Services
Table 51. Yangtze River Pharmaceutical Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Yangtze River Pharmaceutical Recent Developments/Updates
Table 53. Humanwell Healthcare Basic Information, Manufacturing Base and Competitors
Table 54. Humanwell Healthcare Major Business
Table 55. Humanwell Healthcare Nervous System Medications Product and Services
Table 56. Humanwell Healthcare Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Humanwell Healthcare Recent Developments/Updates
Table 58. CSPC-NBP Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 59. CSPC-NBP Pharmaceutical Major Business
Table 60. CSPC-NBP Pharmaceutical Nervous System Medications Product and Services
Table 61. CSPC-NBP Pharmaceutical Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. CSPC-NBP Pharmaceutical Recent Developments/Updates
Table 63. Nhwa Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. Nhwa Pharmaceutical Major Business
Table 65. Nhwa Pharmaceutical Nervous System Medications Product and Services
Table 66. Nhwa Pharmaceutical Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Nhwa Pharmaceutical Recent Developments/Updates
Table 68. Qilu Pharma Basic Information, Manufacturing Base and Competitors
Table 69. Qilu Pharma Major Business
Table 70. Qilu Pharma Nervous System Medications Product and Services
Table 71. Qilu Pharma Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Qilu Pharma Recent Developments/Updates
Table 73. Global Nervous System Medications Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 74. Global Nervous System Medications Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Nervous System Medications Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 76. Market Position of Manufacturers in Nervous System Medications, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Nervous System Medications Production Site of Key Manufacturer
Table 78. Nervous System Medications Market: Company Product Type Footprint
Table 79. Nervous System Medications Market: Company Product Application Footprint
Table 80. Nervous System Medications New Market Entrants and Barriers to Market Entry
Table 81. Nervous System Medications Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Nervous System Medications Sales Quantity by Region (2018-2023) & (K Units)
Table 83. Global Nervous System Medications Sales Quantity by Region (2024-2029) & (K Units)
Table 84. Global Nervous System Medications Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Nervous System Medications Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Nervous System Medications Average Price by Region (2018-2023) & (US$/Unit)
Table 87. Global Nervous System Medications Average Price by Region (2024-2029) & (US$/Unit)
Table 88. Global Nervous System Medications Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Global Nervous System Medications Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Global Nervous System Medications Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Nervous System Medications Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Nervous System Medications Average Price by Type (2018-2023) & (US$/Unit)
Table 93. Global Nervous System Medications Average Price by Type (2024-2029) & (US$/Unit)
Table 94. Global Nervous System Medications Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Global Nervous System Medications Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Global Nervous System Medications Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Nervous System Medications Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Nervous System Medications Average Price by Application (2018-2023) & (US$/Unit)
Table 99. Global Nervous System Medications Average Price by Application (2024-2029) & (US$/Unit)
Table 100. North America Nervous System Medications Sales Quantity by Type (2018-2023) & (K Units)
Table 101. North America Nervous System Medications Sales Quantity by Type (2024-2029) & (K Units)
Table 102. North America Nervous System Medications Sales Quantity by Application (2018-2023) & (K Units)
Table 103. North America Nervous System Medications Sales Quantity by Application (2024-2029) & (K Units)
Table 104. North America Nervous System Medications Sales Quantity by Country (2018-2023) & (K Units)
Table 105. North America Nervous System Medications Sales Quantity by Country (2024-2029) & (K Units)
Table 106. North America Nervous System Medications Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Nervous System Medications Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Nervous System Medications Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Europe Nervous System Medications Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Europe Nervous System Medications Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Europe Nervous System Medications Sales Quantity by Application (2024-2029) & (K Units)
Table 112. Europe Nervous System Medications Sales Quantity by Country (2018-2023) & (K Units)
Table 113. Europe Nervous System Medications Sales Quantity by Country (2024-2029) & (K Units)
Table 114. Europe Nervous System Medications Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Nervous System Medications Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Nervous System Medications Sales Quantity by Type (2018-2023) & (K Units)
Table 117. Asia-Pacific Nervous System Medications Sales Quantity by Type (2024-2029) & (K Units)
Table 118. Asia-Pacific Nervous System Medications Sales Quantity by Application (2018-2023) & (K Units)
Table 119. Asia-Pacific Nervous System Medications Sales Quantity by Application (2024-2029) & (K Units)
Table 120. Asia-Pacific Nervous System Medications Sales Quantity by Region (2018-2023) & (K Units)
Table 121. Asia-Pacific Nervous System Medications Sales Quantity by Region (2024-2029) & (K Units)
Table 122. Asia-Pacific Nervous System Medications Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Nervous System Medications Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Nervous System Medications Sales Quantity by Type (2018-2023) & (K Units)
Table 125. South America Nervous System Medications Sales Quantity by Type (2024-2029) & (K Units)
Table 126. South America Nervous System Medications Sales Quantity by Application (2018-2023) & (K Units)
Table 127. South America Nervous System Medications Sales Quantity by Application (2024-2029) & (K Units)
Table 128. South America Nervous System Medications Sales Quantity by Country (2018-2023) & (K Units)
Table 129. South America Nervous System Medications Sales Quantity by Country (2024-2029) & (K Units)
Table 130. South America Nervous System Medications Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Nervous System Medications Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Nervous System Medications Sales Quantity by Type (2018-2023) & (K Units)
Table 133. Middle East & Africa Nervous System Medications Sales Quantity by Type (2024-2029) & (K Units)
Table 134. Middle East & Africa Nervous System Medications Sales Quantity by Application (2018-2023) & (K Units)
Table 135. Middle East & Africa Nervous System Medications Sales Quantity by Application (2024-2029) & (K Units)
Table 136. Middle East & Africa Nervous System Medications Sales Quantity by Region (2018-2023) & (K Units)
Table 137. Middle East & Africa Nervous System Medications Sales Quantity by Region (2024-2029) & (K Units)
Table 138. Middle East & Africa Nervous System Medications Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Nervous System Medications Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Nervous System Medications Raw Material
Table 141. Key Manufacturers of Nervous System Medications Raw Materials
Table 142. Nervous System Medications Typical Distributors
Table 143. Nervous System Medications Typical Customers
List of Figures
Figure 1. Nervous System Medications Picture
Figure 2. Global Nervous System Medications Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Nervous System Medications Consumption Value Market Share by Type in 2022
Figure 4. Anesthetic Examples
Figure 5. Painkiller Examples
Figure 6. Psychostimulants Examples
Figure 7. Antiepileptic Drugs Examples
Figure 8. Anti-Parkinson Drugs Examples
Figure 9. Others Examples
Figure 10. Global Nervous System Medications Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 11. Global Nervous System Medications Consumption Value Market Share by Application in 2022
Figure 12. Hospital Pharmacy Examples
Figure 13. Retail Pharmacy Examples
Figure 14. Online Pharmacy Examples
Figure 15. Global Nervous System Medications Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Nervous System Medications Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Nervous System Medications Sales Quantity (2018-2029) & (K Units)
Figure 18. Global Nervous System Medications Average Price (2018-2029) & (US$/Unit)
Figure 19. Global Nervous System Medications Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global Nervous System Medications Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of Nervous System Medications by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Nervous System Medications Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 Nervous System Medications Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global Nervous System Medications Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global Nervous System Medications Consumption Value Market Share by Region (2018-2029)
Figure 26. North America Nervous System Medications Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe Nervous System Medications Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific Nervous System Medications Consumption Value (2018-2029) & (USD Million)
Figure 29. South America Nervous System Medications Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa Nervous System Medications Consumption Value (2018-2029) & (USD Million)
Figure 31. Global Nervous System Medications Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global Nervous System Medications Consumption Value Market Share by Type (2018-2029)
Figure 33. Global Nervous System Medications Average Price by Type (2018-2029) & (US$/Unit)
Figure 34. Global Nervous System Medications Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global Nervous System Medications Consumption Value Market Share by Application (2018-2029)
Figure 36. Global Nervous System Medications Average Price by Application (2018-2029) & (US$/Unit)
Figure 37. North America Nervous System Medications Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America Nervous System Medications Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America Nervous System Medications Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America Nervous System Medications Consumption Value Market Share by Country (2018-2029)
Figure 41. United States Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe Nervous System Medications Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe Nervous System Medications Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe Nervous System Medications Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe Nervous System Medications Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific Nervous System Medications Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific Nervous System Medications Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific Nervous System Medications Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific Nervous System Medications Consumption Value Market Share by Region (2018-2029)
Figure 57. China Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America Nervous System Medications Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America Nervous System Medications Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America Nervous System Medications Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America Nervous System Medications Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa Nervous System Medications Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa Nervous System Medications Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa Nervous System Medications Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa Nervous System Medications Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Nervous System Medications Market Drivers
Figure 78. Nervous System Medications Market Restraints
Figure 79. Nervous System Medications Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Nervous System Medications in 2022
Figure 82. Manufacturing Process Analysis of Nervous System Medications
Figure 83. Nervous System Medications Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source